Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Active, not recruiting1
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

active_not_recruiting133%
completed133%
terminated133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruitingnot_applicable

Intestinal Organoids

NCT05294107
terminated

Electrogram-Guided Myocardial Advanced Phenotyping

NCT03293381
completed

microRNAs in Systemic Scleroderma

NCT04148716

Clinical Trials (3)

Showing 3 of 3 trials
NCT05294107Not Applicable

Intestinal Organoids

Active Not Recruiting
NCT03293381

Electrogram-Guided Myocardial Advanced Phenotyping

Terminated
NCT04148716

microRNAs in Systemic Scleroderma

Completed

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3